BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Blockade Medical Announces 510(k) Clearance of the Barricade Coil System


4/29/2013 8:55:33 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

IRVINE, Calif.--(BUSINESS WIRE)-- Blockade Medical L.L.C., a privately held company focused on the development of catheter based therapeutic devices for the treatment of cerebral aneurysms, announced today that the Barricade Coil SystemTM has received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) and that the first series of clinical cases treated with the Barricade Coil System in the United States has been successfully completed.

Rush University Medical Center in Chicago, Illinois was the first center in the United States to use the Barricade Coil System. Michael Chen, M.D. commented, “The softness profile of the finishing coils proved very helpful in my case. They provided the ability to effectively pack the aneurysm while providing a stable microcatheter.”

“Our initial clinical experience with the Barricade Coil System has been positive. The Barricade Coil System is a full coil line which can be successfully used to treat a variety of morphologies. We have been particularly impressed with the softness and deliverability profile of the finishing coil which is competitive to any other coil currently on the market,” said Dr. Alex Spiotta, M.D. from the Medical University of South Carolina in Charleston, South Carolina.

“We are very pleased to have received FDA clearance for the Barricade Coil system. This is a significant achievement as we continue the successful commercialization of the Barricade Coil System. The initial clinical feedback in the United States reinforces the positive feedback from our international experience and we look forward to impacting patient lives in a positive way,” said Gibb Clarke, Blockade Medical’s CEO.

About the Barricade Coil System:

The Barricade Coil System is an embolization coil line which is designed to endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. The Barricade Coil System is a comprehensive bare platinum coil line available in framing, filling and finishing shapes. The Barricade Coil System received CE Mark in July, 2012.

About Blockade Medical:

Blockade Medical is a privately held medical device company focused on expanding the endovascular management of hemorrhagic stroke and related disease of the neurovascular system. The company manufactures the Barricade Coil System in The United States and is based in Irvine, California.

Contact:

Blockade Medical

Ryan Solomon

Director of Global Marketing

949-788-1443



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES